Our data are at variance with the findings reported by Arts et al. (46) who demonstrated that in smooth muscle cells SSc IgG engaged PDGFR leading to the activation of the epidermal growth factor receptor through a PDGFR-independent pathway. The gene discussed is EGFR; the disease is systemic sclerosis.